SCHEMBL76433

SCHEMBL76433

NCc1ccc(N)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2545537 1.00 LOXL2 (1.00)
Hydrochloric Acid SCHEMBL10796330 0.97 LOXL2 (0.94)
Hydrochloric Acid SCHEMBL3171444 0.97 LOXL2 (0.94)
SCHEMBL3787138 0.91 LOXL2 (0.83)
Hydrochloric Acid SCHEMBL31716096 0.89 LOXL2 (0.79)
SCHEMBL15828 0.86 HRH3 (0.79)
Benzylamine SCHEMBL23044693 0.85 LOXL2 (0.78)
Sulfuric Acid SCHEMBL2925225 0.84 LOXL2 (0.71)
SCHEMBL12634637 0.84 LOXL2 (0.71)
SCHEMBL12973290 0.84 LOXL2 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4638 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP claimed
US-20260027220-A1 EPHA2 BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2026-01-29 US claimed
EP-4676540-A1 PANRAS INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF Novartis AG (CH) 2026-01-14 EP claimed
US-20250387504-A1 ANTIBODY-DRUG CONJUGATES OF ANTINEOPLASTIC COMPOUNDS AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2025-12-25 US claimed
US-20250376438-A1 METHOD FOR PRODUCING ISOCYANATES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES COVESTRO DEUTSCHLAND AG (DE) 2025-12-11 US claimed
EP-4652212-A1 PROCESS FOR PREPARING STORAGE-STABLE ISOCYANATE-TERMINATED PREPOLYMERS WITH LONG PROCESSING LIFE Covestro Deutschland AG (DE) 2025-11-26 EP claimed
US-20250339547-A1 MET BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2025-11-06 US claimed
CN-119143691-B Thiadiazole derivative and preparation method and application thereof 山东大学日照研究院 2025-06-24 CN claimed
US-20250188600-A1 SIDEWALL PASSIVATION USING ALDEHYDE OR ISOCYANATE CHEMISTRY FOR HIGH ASPECT RATIO ETCH LAM RESEARCH CORPORATION 2025-06-12 US claimed
WO-2025111431-A1 ANTI-CD7 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF LES LABORATOIRES SERVIER (FR) 2025-05-30 WO claimed
EP-0173629-B1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1992-06-10 EP claimed
US-4978792-A CATALYTIC REDUCTION OF M-OR P-NITROBENZALDEHYDE MITSUI TOATSU CHEMICALS, INC. (JP) 1990-12-18 US claimed
EP-0372729-A1 Reactive dyes ZENECA LIMITED (GB) 1990-06-13 EP claimed
US-4741900-A Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1988-05-03 US claimed
US-4671890-A CURING AGENT FOR THERMOSETTING RESINS MITSUI TOATSU CHEMICALS, INC. (JP) 1987-06-09 US claimed
WO-1986001410-A1 ANTIBODY-METAL ION COMPLEXES CYTOGEN CORPORATION (US) 1986-03-13 WO claimed
EP-0173629-A1 Antibody-metal ion complexes CYTOGEN CORPORATION (US) 1986-03-05 EP claimed
EP-0137074-A1 Curable compositions containing epoxy resins and salicyloyl hydrocarbylamines and cured compositions thereof THE DOW CHEMICAL COMPANY (US) 1985-04-17 EP claimed
US-4410681-A Epoxy resins cured with salicyloyl hydrocarbylamines THE DOW CHEMICAL COMPANY (US) 1983-10-18 US claimed
US-4297098-A COLOR DEVELOPMENT BY ATMOSPHERIC OXYDATION OF A MIXTURE OF P-PHENYLENEDIAMINE OR 2,4-DIAMINOTOLUENE, PYROGALLOL, AND M-AMINOPHENOL ALBERTO-CULVER COMPANY (US) 1981-10-27 US claimed